Yousif Capital Management LLC Sells 8,267 Shares of Albemarle Co. (NYSE:ALB)

Yousif Capital Management LLC decreased its holdings in Albemarle Co. (NYSE:ALBFree Report) by 10.1% in the fourth quarter, HoldingsChannel.com reports. The fund owned 73,270 shares of the specialty chemicals company’s stock after selling 8,267 shares during the quarter. Yousif Capital Management LLC’s holdings in Albemarle were worth $6,307,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in the business. Quarry LP boosted its stake in Albemarle by 1,400.0% in the 3rd quarter. Quarry LP now owns 270 shares of the specialty chemicals company’s stock worth $26,000 after purchasing an additional 252 shares during the period. Trust Co. of Vermont lifted its holdings in shares of Albemarle by 606.5% in the fourth quarter. Trust Co. of Vermont now owns 325 shares of the specialty chemicals company’s stock worth $28,000 after buying an additional 279 shares in the last quarter. Eastern Bank purchased a new position in Albemarle during the third quarter valued at $31,000. Cromwell Holdings LLC lifted its stake in Albemarle by 61.9% in the 3rd quarter. Cromwell Holdings LLC now owns 387 shares of the specialty chemicals company’s stock worth $37,000 after purchasing an additional 148 shares in the last quarter. Finally, TD Private Client Wealth LLC boosted its holdings in shares of Albemarle by 50.4% during the 3rd quarter. TD Private Client Wealth LLC now owns 394 shares of the specialty chemicals company’s stock valued at $37,000 after purchasing an additional 132 shares during the last quarter. Hedge funds and other institutional investors own 92.87% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts recently commented on ALB shares. Evercore ISI downgraded Albemarle from an “outperform” rating to an “inline” rating in a research report on Wednesday. KeyCorp decreased their price objective on Albemarle from $132.00 to $127.00 and set an “overweight” rating on the stock in a report on Tuesday, November 12th. Truist Financial initiated coverage on Albemarle in a research report on Tuesday, January 28th. They set a “hold” rating and a $96.00 target price for the company. Royal Bank of Canada upped their price target on shares of Albemarle from $108.00 to $133.00 and gave the company an “outperform” rating in a research note on Tuesday, November 12th. Finally, Oppenheimer dropped their price objective on shares of Albemarle from $171.00 to $170.00 and set an “outperform” rating for the company in a research note on Friday, November 8th. One analyst has rated the stock with a sell rating, fifteen have given a hold rating and six have assigned a buy rating to the company. According to MarketBeat.com, Albemarle currently has a consensus rating of “Hold” and a consensus price target of $113.95.

View Our Latest Analysis on Albemarle

Insider Activity at Albemarle

In other news, CEO J Kent Masters sold 2,525 shares of the business’s stock in a transaction dated Thursday, December 5th. The shares were sold at an average price of $101.12, for a total value of $255,328.00. Following the completion of the sale, the chief executive officer now owns 73,747 shares in the company, valued at approximately $7,457,296.64. The trade was a 3.31 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.38% of the stock is owned by company insiders.

Albemarle Price Performance

Albemarle stock opened at $78.99 on Friday. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.44 and a quick ratio of 1.58. The stock has a market cap of $9.28 billion, a price-to-earnings ratio of -4.72, a price-to-earnings-growth ratio of 3.65 and a beta of 1.59. The firm has a 50-day moving average of $92.52 and a two-hundred day moving average of $92.92. Albemarle Co. has a 1 year low of $71.97 and a 1 year high of $143.19.

Albemarle Company Profile

(Free Report)

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.

Further Reading

Want to see what other hedge funds are holding ALB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Albemarle Co. (NYSE:ALBFree Report).

Institutional Ownership by Quarter for Albemarle (NYSE:ALB)

Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.